CASP3 and renal cell carcinoma: We validated the expression and prognostic value of the five candidates, including one protective factor (ACTG1), and four risk factors (IL6, CASP3, ACTB and RAP1B) in RCC patients with lung metastasis (n = 20) by IHC analysis of the bulk RNA‐seq datasets.